The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
AC Immune Q3 EPS $(0.22) Up From $(0.26) YoY
AC Immune (NASDAQ:ACIU) reported quarterly losses of $(0.22) per share. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year.
AC Immune CEO Said Number of Families Affected by Alzheimer’s Could Nearly Triple by 2050 in Interview With German Business Magazine Wirtschaftswoche on Sunday
https://www.reuters.com/business/healthcare-pharmaceuticals/ac-immune-says-number-families-affected-by-alzheimers-could-nearly-triple-by-2021-11-07/
https://www.wiwo.de/unternehmen/industrie/ac-immune-biontech-investoren-steigen-beim-alzheimer-spezialisten-ein/27772700.html
AC Immune Highlights New Data On Investigational Alzheimer’s Disease Candidates Will Be Featured In Scientific Program Of ‘Clinical Trials On Alzheimer’s Disease’ Conference Nov. 9-12, 2021
AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announces that new data on its investigational Alzheimer’s disease
AC Immune Granted Australian Patent Titled ‘1, 3, 4, 5-tetrahydro-2H-pyrido(4,3-b)indole derivatives for the treatment, alleviation or prevention of disorders associated with Tau aggregates like Alzheimer’s disease’
http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do
AC Immune Files For U.S. Patent Titled ‘Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates’
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6704&p=135&f=G&l=50&d=PG01&S1=20210902.PD.&OS=PD/20210902&RS=PD/20210902
Mid-Afternoon Market Update: Spok Holdings Surges On Takeover Offer; Sequential Brands Shares Slide
Toward the end of trading Tuesday, the Dow traded down 0.09% to 35,366.93 while the NASDAQ fell 0.02% to 15,263.43. The S&P also fell, dropping 0.11% to 4,523.94.
Mid-Day Market Update: Zoom Shares Drop After Q2 Results; AC Immune Shares Surge
Midway through trading Tuesday, the Dow traded down 0.01% to 35,396.15 while the NASDAQ fell 0.25% to 15,227.25. The S&P also fell, dropping 0.09% to 4,524.67.